CST3 and COVID-19: The univariate Cox regression analysis revealed that the COVID-19 patients with elevated cystatin C levels were at a higher risk of death (hazard ratio [HR]: 10.213, 95% CI: 3.542–29.451, and p < 0.001) than those in the normal cystatin C group.